Changes in the gastrointestinal tract, cardiovascular function and some drug metabolizing processes in rats and guinea-pigs intoxicated with aflatoxin B1

Polish Journal of Pharmacology

Volumn 50, Issue 2, 1998, Pages 135-141

  Štětinová, Věra ^a   Grossmann, Vojtěch ^a   Květina, Jaroslav ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Aflatoxin B1; Cardiovascular system; Gastrointestinal tract; Liver; Rat

Indexed keywords

AFLATOXIN B;

ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS PARASITICUS; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG CONJUGATION; DRUG GLUCURONIDATION; DRUG METABOLISM; GASTROINTESTINAL TOXICITY; INTOXICATION; LIVER FUNCTION; LIVER TOXICITY; MALE; NONHUMAN; RAT; VASCULAR RESISTANCE;

AFLATOXIN B1; ANIMALS; BIOTRANSFORMATION; DIGESTIVE SYSTEM; GASTRIC ACID; GUINEA PIGS; HEMODYNAMIC PROCESSES; HISTAMINE RELEASE; LETHAL DOSE 50; LIVER FUNCTION TESTS; MALE; PHARMACEUTICAL PREPARATIONS; RATS; RATS, WISTAR; VASCULAR RESISTANCE;

EID: 2642613664     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bortell R., Asquith R. L., Edds G. T., Simpson C. F., Aller W. W.: Acute experimentally induced aflatoxicosis in the weanling pony. Amer. J. Vet. Res., 1983, 44, 2110-2114.
2. Busby W. F., Wogan G. N.: Aflatoxins. In: Mycotoxins and N-Nitroso Compounds: Enviromental Risk. Ed. Shank R. C., CRC Press, Boca Raton, Florida, 1981, vol. 2, 3-27.
3. 1 in rabbit lung and liver microsomes. Carcinogenesis, 1990, 11, 823-827.
4. Dickens F., Jones H. E. H.: The carcinogenic action of aflatoxin after its subcutaneous injection in the rat. Brit. J. Cancer, 1964, 17, 691.
5. 131I-OIBK) (Czech). Čas. Lék. Čes., 1973, 112, 586-594.
6. 1 in two causes of lung cancer in man. J. Cancer Res. Clin. Oncol., 1981, 100, 221-224.
7. Fry J. R., Wiebkin P., Kao J., Jones C. A., Gwynn J., Bridges J. W. A.: A comparison of drug-metabolizing capability in isolated viable rat hepatocytes and renal tubule fragments. Xenobiotica, 1978, 8, 113-120.
8. Fukal L., Reisnerová H.: Monitoring of aflatoxins and ochratoxin A in Czechoslovac human sera by immunoassay. Bull. Environ. Contam. Toxicol., 1990, 44, 345-349.
9. 1 to DNA, RNA, polyribonucleotides and protein in vitro. Chem.-Biol. Inter., 1973, 6, 125-129.
10. Govier W. C.: Reticuloendothelial cells as the site of sulfanilamide acetylation in the rabbit. J. Pharmacol. Exp. Ther., 1965, 150, 305-308.
11. Groopman J. D., Cain L. G., Kensler T. W.: Aflatoxin exposure in human populations: measurements and relationship to cancer. CRC Crit. Rev. Toxicol., 1988, 19, 113-145.
12. 1 (Czech). Čs. Fysiol., 1976, 25, 559.
13. Grossmann V., Kusák V., Štětinová V.: On the problem of influence of mycotoxins from food on the effect of drugs (Czech). Čas. Lék. Čes., 1978, 117, 537-540.
14. Grossmann V., Květina J.: How does first-pass effect occur in the case of ergot alkaloids after peroral administration. In: Proceedings of Third European Congress of Biopharmaceutics and Pharmacokinetics, Freiburg, April 21-24, 1987, vol. II, 1987, 195-202.
15. Halver J. E.: Aflatoxicosis and trout hepatoma. In: Aflatoxin: Scientific Background Control and Implications. Ed. Goldblatt L. A., Academic Press, London, New York, 1969, 265-306.
16. 1 on the reactivity of perifery vessels to histamine (Czech). Annual report ZP 561-507-01-13, 1983, 52, ÚEM ČSAV Olešnice v Orl. horách.
17. Hubálek F., Grossmann V., Doležalová V.: Possibilities of timely biochemical diagnosis of acute poisoning by aflatoxins (Czech). Čs. Hyg., 1982, 27, 20-29.
18. 1-Induced Hepatocarcinogenesis. ACCO, Leuven., 1976, 55-70.
19. 1 in male and female rats: relationship with hepatic drug-metabolizing enzymes. Biochem. Pharmacol., 1982, 31, 3057-3062.
20. 1 in the rat. Toxicol. Lett., Suppl., 1992, 287.
21. 1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology, 1989, 97, 1281-1287.
22. 1. J. Nat. Cancer Inst., 1978, 60, 317-320.
23. Morland J., Olsen H.: Metabolism of sulfamidine, sulfanilamide, p-aminobenzoic acid and nonparenchymal rat liver cells. Drug Metab. Dispos., 1977, 5, 511-517.
24. Newberne P. M., Hunt C. E., Wogan G. N.: Neoplasms in the rat associated with administration of urethan and aflatoxin. Exp. Mol. Pathol., 1967, 6, 285-299.
25. Paterson D. S. P.: Metabolism as a factor in determining toxic action of aflatoxins in different animal species. Food Cosmet. Toxicol., 1973, 11, 287-294.
26. Roháček J., Grossmann V., Janeček L., Kalivoda L., Kusák V.: Doubled electrode for preparation of radiolabelled compounds (Czech). Czechosl. Pat. No 211270, 1984.
27. Shay H., Komarov S. A., Fels S. S., Meranza D., Grunstein M., Siplet A.: A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology, 1945, 5, 43-61.
28. 1 from feeding mixture on formation of residua in tissue of domestic fowl, goose, turkey. In: Proceedings of Congress of Rational Animal Feed, Štrbské Pleso, November 9-10 (Czech), 1982, 167-170.
29. 1). Toxicol. Lett., Suppl., 1992, 128.
30. 1 on the sensitivity of the rat central nervous system to pentobarbital-Na racemate. Pol. J. Pharmacol., 1995, 47, 393-399.
31. Stoloff L.: Aflatoxin is not a probable human carcinogen: the published evidence is sufficient. Regul. Toxicol. Pharmacol., 1989, 10, 272-283.
32. 4 and liver enzymes and histopathologic changes. Amer. J. Vet. Res., 1980, 41, 1272-1276.
33. Tung H., Donaldson W. W., Hamilton P. B.: Effects of aflatoxin on some marker enzymes of lysosomes. Biochem. Biophys. Acta, 1970, 222, 665-672.
34. 1 by bacterial recombinant human cytochrome P450 enzyme, Chem. Res. Toxicol., 1995, 8, 218-225.
35. Wogan G. N., Edwards G. S., Newberne P. M.: Structure-activity relationships in toxicity and carcinogenity of aflatoxins and analogs. Cancer Res., 1971, 31, 1936-1942.